Login
$ADAG
$1.60 -$0.11 (6.43%) Live

Company Executives

Officer In this role Source
Peter Luo Also a director
Co-Founder, Chief Executive Officer, President of R&D, and Chairman of the Board
Not stated
Man Kin (Raymond) Tam Also a director
Chief Financial Officer and Director
Not stated
Qinghai Zhao
Chief Manufacturing Officer
Since 2020
6 years
Mickael Chane-Du
Chief Strategy Officer
Not stated
Yan Li
Senior Vice President, Bioinformatics and Information Technology
Since 2011
15 years
Xiaohong (Kristine) She
Senior Vice President, Head of Clinical Operations
Since 2011
15 years
Guizhong Liu
Senior Vice President of Early Drug Discovery
Since 2023
3 years
Songmao Zheng
Senior Vice President of Clinical Pharmacology and Quantitative Sciences
Not stated
Jiping Zha
Executive Vice President of Clinical Development
Since 2021
5 years
Alexander Goergen
Vice President, Head of Business Development
Since 2017
9 years
Wenlin Zeng
Vice President of Early Stage CMC
Since 2021
5 years
Chunfang (Vicky) Gu
Executive Director of Finance
Not stated
Ling (Jolin) Zhou
Executive Director of Human Resources
Since 2019
7 years

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the 20-F annual report

Directors
6
serving now
Independent
2 of 2
stated in the proxy; 4 not stated
Average tenure
3.8 years
from year joined
CEO also chairs the board
Yes
Peter Luo
Director On board Independent Committees Pay Source
Peter Luo
Not stated Not stated
Compensation Committee · Chair Nominating and Corporate Governance Committee · Chair
Paid as CEO
Man Kin (Raymond) Tam
2021
5 years
Not stated None stated Not stated
Andy (Yiu Leung) Cheung
2021
5 years
Independent
Audit Committee · Chair Compensation Committee Nominating and Corporate Governance Committee
Not stated
Cuong Do
2022
4 years
Independent
Audit Committee
Not stated
Li Zhu
2023
3 years
Not stated
Compensation Committee
Not stated
Ulf Grawunder
2024
2 years
Not stated
Audit Committee
Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No proxy statement on record

Related-party transactions come from the company’s proxy statement. Adagene Inc. has not filed one with the SEC.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support